Fingerprint
Dive into the research topics of 'Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial
Paul Rutgeerts, William J Sandborn, Richard N Fedorak, Daniel Rachmilewitz, Dino Tarabar, Peter Gibson, Ole Haagen Nielsen, Gary Wild, Stefan Schreiber, Claudia Pena Rossi, Monia Zignani, Onercept Study Group